Cutting edge issues in Goodpasture's disease

Clinical Reviews in Allergy and Immunology

Volumn 41, Issue 2, 2011, Pages 151-162

  Chan, Andrew L ^a   Louie, Samuel ^a   Leslie, Kevin O ^b   Juarez, Maya M ^a   Albertson, Timothy E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Alveolar hemorrhage; Anti GBM; Antibodies; Glomerulonephritis; Goodpasture's; Plasmapheresis

Indexed keywords

CARBON MONOXIDE; COCAINE; CORTICOSTEROID; CREATININE; CYCLOPHOSPHAMIDE; GLOMERULUS BASEMENT MEMBRANE ANTIBODY; HEMOGLOBIN; HYDROCARBON; METAL; NEUTROPHIL CYTOPLASMIC ANTIBODY; NITROGEN; OXYHEMOGLOBIN; PROTEINASE; UREA;

ABNORMAL RESPIRATORY SOUND; AMBIENT AIR; ANTIBODY DETECTION; ANTIBODY TITER; ARTHRALGIA; ARTICLE; BODY TEMPERATURE; BREATHING RATE; CAUCASIAN; CD8+ T LYMPHOCYTE; CHEMICAL INJURY; CLINICAL FEATURE; COMPLEMENT ACTIVATION; COMPUTER ASSISTED TOMOGRAPHY; CORTICOSTEROID THERAPY; CREATININE BLOOD LEVEL; CRITICALLY ILL PATIENT; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DYSPNEA; EARLY DIAGNOSIS; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE COUNT; ERYTHROCYTE DISORDER; ERYTHROCYTE SEDIMENTATION RATE; GOODPASTURE SYNDROME; GRANULAR CELL; HEART RATE; HEMOGLOBIN BLOOD LEVEL; HEMOPTYSIS; HUMAN; HYPERTENSION; IMMUNOASSAY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY INJURY; KIDNEY TRANSPLANTATION; LABORATORY TEST; LEG EDEMA; LEUKOCYTE COUNT; LUNG AUSCULTATION; LUNG BURN; LUNG DIFFUSION CAPACITY; LUNG HEMORRHAGE; LUNG INFILTRATE; LUNG INJURY; MEAN CORPUSCULAR HEMOGLOBIN; MEAN CORPUSCULAR VOLUME; MYALGIA; NONHUMAN; OLIGURIA; OXYGEN SATURATION; PATIENT MONITORING; PHYSICAL EXAMINATION; PLASMAPHERESIS; PROGNOSIS; PROTEINURIA; SMOKING; SURFACE PLASMON RESONANCE; THORAX RADIOGRAPHY; THROMBOCYTE COUNT; UREA NITROGEN BLOOD LEVEL; URINALYSIS; VITAL SIGN; WEIGHT REDUCTION;

ANTI-GLOMERULAR BASEMENT MEMBRANE DISEASE; AUTOANTIBODIES; BASEMENT MEMBRANE; COLLAGEN TYPE IV; DIAGNOSIS, DIFFERENTIAL; FEMALE; GLOMERULONEPHRITIS; HEMOPTYSIS; HUMANS; IMMUNOCONJUGATES; IMMUNOSUPPRESSIVE AGENTS; IMMUNOTHERAPY; KIDNEY GLOMERULUS; MIDDLE AGED; PLASMA EXCHANGE; PULMONARY ALVEOLI; RISK FACTORS; SMOKING;

EID: 79960402783     PISSN: 10800549     EISSN: 15590267     Source Type: Journal    
DOI: 10.1007/s12016-010-8222-2     Document Type: Article

References (77)

1. MC Stanton JD Tange 1958 Goodpasture's syndrome (pulmonary haemorrhage associated with glomerulonephritis) Australas Ann Med 7 132 144 13546112 1:STN:280:DyaG1c%2FovFWnsg%3D%3D
2. EW Goodpasture 1919 The significance of certain pulmonary lesions in relation to the etiology of influenza Am J Med Sci 158 863 870 10.1097/00000441-191911000-00012
3. RD Collins 2010 Dr Goodpasture: "I was not aware of such a connection between lung and kidney disease" Ann Diagn Pathol 14 194 198 20471565 10.1016/j.anndiagpath.2010.02.003
4. BG Hudson K Tryggvason M Sundaramoorthy EG Neilson 2003 Alport's syndrome, Goodpasture's syndrome, and type IV collagen N Engl J Med 348 2543 2556 12815141 10.1056/NEJMra022296 1:CAS:528:DC%2BD3sXks12qtrc%3D (Pubitemid 36706542)
5. AD Salama AN Chaudhry JJ Ryan E Eren JB Levy CD Pusey, et al. 2001 In Goodpasture's disease, CD4(+) T cells escape thymic deletion and are reactive with the autoantigen alpha3(IV)NC1 J Am Soc Nephrol 12 1908 1915 11518784 1:CAS:528:DC%2BD3MXmvFKgsrg%3D (Pubitemid 32801366)
6. AD Salama JB Levy L Lightstone CD Pusey 2001 Goodpasture's disease Lancet 358 917 920 11567730 10.1016/S0140-6736(01)06077-9 1:STN:280: DC%2BD3Mrit1entw%3D%3D (Pubitemid 32900581)
7. RW Lee DP D'Cruz 2010 Pulmonary renal vasculitis syndromes Autoimmun Rev 9 657 660 20472100 10.1016/j.autrev.2010.05.012
8. CD Pusey 2003 Anti-glomerular basement membrane disease Kidney Int 64 1535 1550 12969182 10.1046/j.1523-1755.2003.00241.x (Pubitemid 37153829)
9. R Lazor L Bigay-Game V Cottin J Cadranel O Decaux JM Fellrath, et al. 2007 Alveolar hemorrhage in anti-basement membrane antibody disease: a series of 28 cases Medicine (Baltimore) 86 181 193 10.1097/md.0b013e318067da56 (Pubitemid 46787972)
10. C Daly PJ Conlon W Medwar JJ Walshe 1996 Characteristics and outcome of anti-glomerular basement membrane disease: a single-center experience Ren Fail 18 105 112 8820507 10.3109/08860229609052780 1:STN:280:DyaK28vhslOitA%3D%3D (Pubitemid 26073879)
11. CO Savage CD Pusey C Bowman AJ Rees CM Lockwood 1986 Antiglomerular basement membrane antibody mediated disease in the British Isles 1980-4 Br Med J (Clin Res Ed) 292 301 304 10.1136/bmj.292.6516.301 1:STN:280: DyaL287gsFSmtA%3D%3D (Pubitemid 16144622)
12. JB Levy AN Turner AJ Rees CD Pusey 2001 Long-term outcome of anti-glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression Ann Intern Med 134 1033 1042 11388816 1:STN:280: DC%2BD3Mzis1Cnuw%3D%3D (Pubitemid 32488657)
13. JD Ooi SR Holdsworth AR Kitching 2008 Advances in the pathogenesis of Goodpasture's disease: from epitopes to autoantibodies to effector T cells J Autoimmun 31 295 300 18502098 10.1016/j.jaut.2008.04.005 1:CAS:528: DC%2BD1cXhsVWrs73K
14. M Donaghy AJ Rees 1983 Cigarette smoking and lung haemorrhage in glomerulonephritis caused by autoantibodies to glomerular basement membrane Lancet 2 1390 1393 6140495 10.1016/S0140-6736(83)90923-6 1:STN:280: DyaL2c%2Fpt1arsQ%3D%3D
15. RJ Klasa RT Abboud HS Ballon L Grossman 1988 Goodpasture's syndrome: recurrence after a five-year remission. Case report and review of the literature Am J Med 84 751 755 3041810 10.1016/0002-9343(88)90114-3 1:STN:280: DyaL1c3pt1eitw%3D%3D
16. GM Garcia-Rostan y Perez F Garcia Bragado AM Puras Gil 1997 Pulmonary hemorrhage and antiglomerular basement membrane antibody-mediated glomerulonephritis after exposure to smoked cocaine (crack): a case report and review of the literature Pathol Int 47 692 697 9361103 10.1111/j.1440-1827.1997. tb04443.x (Pubitemid 27460758)
17. P Lechleitner M Defregger K Lhotta M Totsch F Fend 1993 Goodpasture's syndrome. Unusual presentation after exposure to hard metal dust Chest 103 956 957 8449104 10.1378/chest.103.3.956 1:STN:280:DyaK3s7ptlGntQ%3D%3D (Pubitemid 23086211)
18. GJ Beirne JT Brennan 1972 Glomerulonephritis associated with hydrocarbon solvents: mediated by antiglomerular basement membrane antibody Arch Environ Health 25 365 369 4568564 1:STN:280:DyaE3s%2FpsVKmtg%3D%3D
19. GJ Bombassei AA Kaplan 1992 The association between hydrocarbon exposure and anti-glomerular basement membrane antibody-mediated disease (Goodpasture's syndrome) Am J Ind Med 21 141 153 1536151 10.1002/ajim.4700210204 1:STN:280:DyaK387mtVOrtw%3D%3D
20. WT Blue CF Lange 1975 Increased immunologic reactivity between human glomerular basement membrane and group A type 12 streptococcal cell membrane after carbohydrase treatment J Immunol 114 306 309 1090650 1:STN:280: DyaE2M7hsFCmug%3D%3D
21. RG Phelps AJ Rees 1999 The HLA complex in Goodpasture's disease: a model for analyzing susceptibility to autoimmunity Kidney Int 56 1638 1653 10571772 10.1046/j.1523-1755.1999.00720.x 1:CAS:528:DyaK1MXnslWqurg%3D (Pubitemid 29518164)
22. F Merkel R Kalluri M Marx U Enders S Stevanovic G Giegerich, et al. 1996 Autoreactive T-cells in Goodpasture's syndrome recognize the N-terminal NC1 domain on alpha 3 type IV collagen Kidney Int 49 1127 1133 8691734 10.1038/ki.1996.163 1:STN:280:DyaK283lsFWmtw%3D%3D (Pubitemid 26122716)
23. D Wong RG Phelps AN Turner 2001 The Goodpasture antigen is expressed in the human thymus Kidney Int 60 1777 1783 11703595 10.1046/j.1523-1755.2001. 00014.x 1:CAS:528:DC%2BD3MXotlGnsbY%3D (Pubitemid 32999982)
24. D Wolf K Hochegger AM Wolf HF Rumpold G Gastl H Tilg, et al. 2005 CD4 + CD25+ regulatory T cells inhibit experimental anti-glomerular basement membrane glomerulonephritis in mice J Am Soc Nephrol 16 1360 1370 15788479 10.1681/ASN.2004100837 1:CAS:528:DC%2BD2MXksF2gsLg%3D (Pubitemid 41716520)
25. AD Salama AN Chaudhry KA Holthaus K Mosley R Kalluri MH Sayegh, et al. 2003 Regulation by CD25+ lymphocytes of autoantigen-specific T-cell responses in Goodpasture's (anti-GBM) disease Kidney Int 64 1685 1694 14531801 10.1046/j.1523-1755.2003.00259.x 1:CAS:528:DC%2BD3sXpsVCrtrg%3D (Pubitemid 37323697)
26. J Wu J Hicks C Ou D Singleton J Borillo YH Lou 2001 Glomerulonephritis induced by recombinant collagen IV alpha 3 chain noncollagen domain 1 is not associated with glomerular basement membrane antibody: a potential T cell-mediated mechanism J Immunol 167 2388 2395 11490029 1:CAS:528: DC%2BD3MXlvFCjsLw%3D (Pubitemid 32747554)
27. J Wu J Hicks J Borillo WF Glass 2nd YH Lou 2002 CD4(+) T cells specific to a glomerular basement membrane antigen mediate glomerulonephritis J Clin Invest 109 517 524 11854324 1:CAS:528:DC%2BD38XhsVSkt7o%3D (Pubitemid 34171783)
28. R Kalluri TM Danoff H Okada EG Neilson 1997 Susceptibility to anti-glomerular basement membrane disease and Goodpasture syndrome is linked to MHC class II genes and the emergence of T cell-mediated immunity in mice J Clin Invest 100 2263 2275 9410904 10.1172/JCI119764 1:CAS:528:DyaK2sXnt1GgsL0%3D (Pubitemid 27500149)
29. J Reynolds VA Norgan U Bhambra J Smith HT Cook CD Pusey 2002 Anti-CD8 monoclonal antibody therapy is effective in the prevention and treatment of experimental autoimmune glomerulonephritis J Am Soc Nephrol 13 359 369 11805163 1:CAS:528:DC%2BD38XhtlWjurc%3D (Pubitemid 34106277)
30. J Reynolds SB Khan AR Allen CD Benjamin CD Pusey 2004 Blockade of the CD154-CD40 costimulatory pathway prevents the development of experimental autoimmune glomerulonephritis Kidney Int 66 1444 1452 15458437 10.1111/j.1523-1755.2004.00907.x 1:CAS:528:DC%2BD2cXpsVShtb4%3D (Pubitemid 39298376)
31. M Segelmark R Butkowski J Wieslander 1990 Antigen restriction and IgG subclasses among anti-GBM autoantibodies Nephrol Dial Transplant 5 991 996 2128958 1:STN:280:DyaK3M3mtFahsA%3D%3D
32. R Kalluri CB Wilson M Weber S Gunwar AM Chonko EG Neilson, et al. 1995 Identification of the alpha 3 chain of type IV collagen as the common autoantigen in antibasement membrane disease and Goodpasture syndrome J Am Soc Nephrol 6 1178 1185 8589284 1:STN:280:DyaK287jtVCqsg%3D%3D
33. J Saus J Wieslander JP Langeveld S Quinones BG Hudson 1988 Identification of the Goodpasture antigen as the alpha 3(IV) chain of collagen IV J Biol Chem 263 13374 13380 3417661 1:CAS:528:DyaL1cXlvVGkurs%3D
34. J Wieslander JF Barr RJ Butkowski SJ Edwards P Bygren D Heinegard, et al. 1984 Goodpasture antigen of the glomerular basement membrane: localization to noncollagenous regions of type IV collagen Proc Natl Acad Sci USA 81 3838 3842 6328527 10.1073/pnas.81.12.3838 1:CAS:528:DyaL2cXksFaqtbo%3D (Pubitemid 14087813)
35. V Pedchenko O Bondar AB Fogo R Vanacore P Voziyan AR Kitching, et al. 2010 Molecular architecture of the Goodpasture autoantigen in anti-GBM nephritis N Engl J Med 363 343 354 20660402 10.1056/NEJMoa0910500 1:CAS:528: DC%2BC3cXptFSlsLw%3D
36. DJ Salant 2010 Goodpasture's disease-new secrets revealed N Engl J Med 363 388 391 20660408 10.1056/NEJMe1006301 1:CAS:528:DC%2BC3cXptFSrs7k%3D
37. N Turner PJ Mason R Brown M Fox S Povey A Rees, et al. 1992 Molecular cloning of the human Goodpasture antigen demonstrates it to be the alpha 3 chain of type IV collagen J Clin Invest 89 592 601 1737849 10.1172/JCI115625 1:CAS:528:DyaK38Xht1Knt7g%3D
38. M Abbate R Kalluri D Corna N Yamaguchi RT McCluskey BG Hudson, et al. 1998 Experimental Goodpasture's syndrome in Wistar-Kyoto rats immunized with alpha3 chain of type IV collagen Kidney Int 54 1550 1561 9844131 10.1046/j.1523-1755.1998.00153.x 1:CAS:528:DyaK1cXnsVeqtLw%3D (Pubitemid 28502897)
39. R Kalluri MJ Sun BG Hudson EG Neilson 1996 The Goodpasture autoantigen. Structural delineation of two immunologically privileged epitopes on alpha3(IV) chain of type IV collagen J Biol Chem 271 9062 9068 8621555 10.1074/jbc.271.15. 9062 1:CAS:528:DyaK28Xitlentb0%3D (Pubitemid 26123338)
40. CE Kashtan 2001 Familial hematuric syndromes-Alport syndrome, thin glomerular basement membrane disease and Fechtner/Epstein syndromes Contrib Nephrol 136 79 99 11688406 10.1159/000060181 1:CAS:528:DC%2BD38XjslynsA%3D%3D
41. JP Grunfeld 2000 Contemporary diagnostic approach in Alport's syndrome Ren Fail 22 759 763 11104163 10.1081/JDI-100101961 1:STN:280: DC%2BD3M7ltVKquw%3D%3D
42. DA Williamson 1961 Alport's syndrome of hereditary nephritis with deafness Lancet 2 1321 1323 14007240 10.1016/S0140-6736(61)90899-6 1:STN:280:DyaF387pvFWnug%3D%3D
43. CE Kashtan AF Michael 1996 Alport syndrome Kidney Int 50 1445 1463 8914010 10.1038/ki.1996.459 1:CAS:528:DyaK28Xms1Oks7s%3D (Pubitemid 26364249)
44. BG Hudson R Kalluri S Gunwar M Weber F Ballester JK Hudson, et al. 1992 The pathogenesis of Alport syndrome involves type IV collagen molecules containing the alpha 3(IV) chain: evidence from anti-GBM nephritis after renal transplantation Kidney Int 42 179 187 1635348 10.1038/ki.1992.276 1:STN:280:DyaK38zktFKqtA%3D%3D
45. JS Kang CE Kashtan AN Turner L Heidet BG Hudson DB Borza 2007 The alloantigenic sites of alpha3alpha4alpha5(IV) collagen: pathogenic X-linked alport alloantibodies target two accessible conformational epitopes in the alpha5NC1 domain J Biol Chem 282 10670 10677 17293596 10.1074/jbc.M611892200 1:CAS:528:DC%2BD2sXjs1Shs74%3D (Pubitemid 47093427)
46. R Kalluri A Torre CF Shield 3rd ED Zamborsky MC Werner E Suchin, et al. 2000 Identification of alpha3, alpha4, and alpha5 chains of type IV collagen as alloantigens for Alport posttransplant anti-glomerular basement membrane antibodies Transplantation 69 679 683 10708133 10.1097/00007890-200002270-00038 1:CAS:528:DC%2BD3cXhvFOgtL4%3D (Pubitemid 30129611)
47. CE Kashtan 2006 Renal transplantation in patients with Alport syndrome Pediatr Transplant 10 651 657 16911486 10.1111/j.1399-3046.2006.00528.x (Pubitemid 44186284)
48. NS Sheerin T Springall MC Carroll B Hartley SH Sacks 1997 Protection against anti-glomerular basement membrane (GBM)-mediated nephritis in C3- and C4-deficient mice Clin Exp Immunol 110 403 409 9409643 10.1046/j.1365-2249.1997. 4261438.x 1:STN:280:DyaK1c%2Fnt1ejsw%3D%3D (Pubitemid 27525271)
49. WH Baricos SL Cortez QC Le LT Wu E Shaw K Hanada, et al. 1991 Evidence suggesting a role for cathepsin L in an experimental model of glomerulonephritis Arch Biochem Biophys 288 468 472 1898042 10.1016/0003-9861(91)90222-5 1:CAS:528:DyaK3MXksVOmurw%3D
50. AR Kitching PG Tipping SR Holdsworth 1999 IL-12 directs severe renal injury, crescent formation and Th1 responses in murine glomerulonephritis Eur J Immunol 29 1 10 9933080 10.1002/(SICI)1521-4141(199901)29:01<1::AID- IMMU1>3.0.CO;2-R 1:CAS:528:DyaK1MXhtVOhsbk%3D (Pubitemid 29043516)
51. JR Timoshanko SR Holdsworth AR Kitching PG Tipping 2002 IFN-gamma production by intrinsic renal cells and bone marrow-derived cells is required for full expression of crescentic glomerulonephritis in mice J Immunol 168 4135 4141 11937574 1:CAS:528:DC%2BD38XivV2isbw%3D (Pubitemid 34298422)
52. G Remuzzi T Bertani 1998 Pathophysiology of progressive nephropathies N Engl J Med 339 1448 1456 9811921 10.1056/NEJM199811123392007 1:CAS:528:DyaK1cXnsFCqt70%3D (Pubitemid 28516069)
53. DC Kluth AJ Rees 1999 Anti-glomerular basement membrane disease J Am Soc Nephrol 10 2446 2453 10541306 1:STN:280:DC%2BD3c%2Fgsleiuw%3D%3D (Pubitemid 29501480)
54. AR Lara MI Schwarz 2010 Diffuse alveolar hemorrhage Chest 137 1164 1171 20442117 10.1378/chest.08-2084
55. MR Zamora ML Warner R Tuder MI Schwarz 1997 Diffuse alveolar hemorrhage and systemic lupus erythematosus. Clinical presentation, histology, survival, and outcome Medicine (Baltimore) 76 192 202 10.1097/00005792-199705000-00005 1:STN:280:DyaK2szjs1OjtQ%3D%3D (Pubitemid 27255822)
56. C Ang J Savige J Dawborn P Miach W Heale B Clarke, et al. 1998 Anti-glomerular basement membrane (GBM)-antibody-mediated disease with normal renal function Nephrol Dial Transplant 13 935 939 9568853 10.1093/ndt/13.4.935 1:STN:280:DyaK1c3islyjtQ%3D%3D (Pubitemid 28161767)
57. K de Groot A Schnabel 2005 Pulmonary-renal syndrome Internist (Berl) 46 769 781 10.1007/s00108-005-1423-8 quiz 782 (Pubitemid 40984819)
58. R Cervera S Bucciarelli MA Plasin JA Gomez-Puerta J Plaza G Pons-Estel, et al. 2009 Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of a series of 280 patients from the "CAPS Registry" J Autoimmun 32 240 245 19324520 10.1016/j.jaut.2009.02.008 1:CAS:528:DC%2BD1MXls12qsLY%3D
59. JW Leatherman 1987 Immune alveolar hemorrhage Chest 91 891 897 3556057 10.1378/chest.91.6.891 1:STN:280:DyaL2s3hslKjsA%3D%3D
60. AD Salama T Dougan JB Levy HT Cook SH Morgan S Naudeer, et al. 2002 Goodpasture's disease in the absence of circulating anti-glomerular basement membrane antibodies as detected by standard techniques Am J Kidney Dis 39 1162 1167 12046026 10.1053/ajkd.2002.33385 (Pubitemid 34591930)
61. RA Sinico A Radice C Corace E Sabadini B Bollini 2006 Anti-glomerular basement membrane antibodies in the diagnosis of Goodpasture syndrome: a comparison of different assays Nephrol Dial Transplant 21 397 401 16234289 10.1093/ndt/gfi230 1:CAS:528:DC%2BD28Xmsl2htg%3D%3D (Pubitemid 43159994)
62. Levy JB, Pusey CD (1997) Anti-GBM antibody mediated disease. In: Wilkinson R Jr (ed) Nephrology. Chapman & Hall, London, pp 599-615
63. P Gris Y Pirson J Hamels JP Vaerman A Quoidbach H Demol 1991 Antiglomerular basement membrane nephritis induced by IgA1 antibodies Nephron 58 418 424 1922606 10.1159/000186473 1:STN:280:DyaK38%2FhvVGgtA%3D%3D
64. A Rutgers KE Meyers G Canziani R Kalluri J Lin MP Madaio 2000 High affinity of anti-GBM antibodies from Goodpasture and transplanted Alport patients to alpha3(IV)NC1 collagen Kidney Int 58 115 122 10886555 10.1046/j.1523-1755.2000.00146.x 1:CAS:528:DC%2BD3cXltVyjtL4%3D (Pubitemid 30429855)
65. CB Wilson FJ Dixon 1974 Diagnosis of immunopathologic renal disease Kidney Int 5 389 401 4278855 10.1038/ki.1974.57 1:STN:280:DyaE2M%2FivFCjtw%3D%3D
66. JB Levy T Hammad A Coulthart T Dougan CD Pusey 2004 Clinical features and outcome of patients with both ANCA and anti-GBM antibodies Kidney Int 66 1535 1540 15458448 10.1111/j.1523-1755.2004.00917.x 1:CAS:528:DC%2BD2cXpsVShu7c%3D (Pubitemid 39298387)
67. X Bosch E Mirapeix J Font X Borrellas R Rodriguez A Lopez-Soto, et al. 1991 Prognostic implication of anti-neutrophil cytoplasmic autoantibodies with myeloperoxidase specificity in anti-glomerular basement membrane disease Clin Nephrol 36 107 113 1657470 1:STN:280:DyaK38%2FjsFyisg%3D%3D
68. CM Lombard TV Colby CG Elliott 1989 Surgical pathology of the lung in anti-basement membrane antibody-associated Goodpasture's syndrome Hum Pathol 20 445 451 2707796 10.1016/0046-8177(89)90009-9 1:STN:280:DyaL1M3ht1Gmuw%3D%3D (Pubitemid 19134348)
69. CM Lockwood DK Peters 1980 Plasma exchange in glomerulonephritis and related vasculitides Annu Rev Med 31 167 179 6994604 10.1146/annurev.me.31. 020180.001123 1:STN:280:DyaL3c3ktVOjtQ%3D%3D
70. MH Mokrzycki AA Kaplan 1994 Therapeutic plasma exchange: complications and management Am J Kidney Dis 23 817 827 8203364 1:STN:280:DyaK2c3mt1GqtQ%3D%3D (Pubitemid 24173565)
71. CM Lockwood AJ Rees TA Pearson DJ Evans DK Peters CB Wilson 1976 Immunosuppression and plasma-exchange in the treatment of Goodpasture's syndrome Lancet 1 711 715 56532 10.1016/S0140-6736(76)93089-0 1:STN:280: DyaE287kvVKgsA%3D%3D
72. KO Netzer F Merkel M Weber 1998 Goodpasture syndrome and end-stage renal failure-to transplant or not to transplant? Nephrol Dial Transplant 13 1346 1348 9641155 1:STN:280:DyaK1czgt1ymtQ%3D%3D (Pubitemid 28254300)
73. JB Levy RH Lachmann CD Pusey 1996 Recurrent Goodpasture's disease Am J Kidney Dis 27 573 578 8678069 10.1016/S0272-6386(96)90169-9 1:STN:280: DyaK283nt1ehsA%3D%3D (Pubitemid 26106606)
74. J Reynolds FW Tam A Chandraker J Smith AM Karkar J Cross, et al. 2000 CD28-B7 blockade prevents the development of experimental autoimmune glomerulonephritis J Clin Invest 105 643 651 10712436 10.1172/JCI6710 1:CAS:528:DC%2BD3cXhslygsbY%3D (Pubitemid 30146511)
75. K Laczika S Knapp K Derfler A Soleiman WH Horl W Druml 2000 Immunoadsorption in Goodpasture's syndrome Am J Kidney Dis 36 392 395 10922318 10.1053/ajkd.2000.8993 1:STN:280:DC%2BD3cvhs1eltg%3D%3D (Pubitemid 30485848)
76. S Lovric A Lukasz C Hafer JT Kielstein M Haubitz H Haller, et al. 2010 Removal of elevated circulating angiopoietin-2 by plasma exchange-A pilot study in critically ill patients with thrombotic microangiopathy and anti-glomerular basement membrane disease Thromb Haemost 104 1038 1043 20806109 10.1160/TH10-02-0138 1:CAS:528:DC%2BC3cXhsFaht7zE
77. PG Tipping AR Kitching XR Huang DA Mutch SR Holdsworth 1997 Immune modulation with interleukin-4 and interleukin-10 prevents crescent formation and glomerular injury in experimental glomerulonephritis Eur J Immunol 27 530 537 9045927 10.1002/eji.1830270226 1:CAS:528:DyaK2sXis1Gjsb0%3D (Pubitemid 27085260)